Current Diabetes Reports

, Volume 12, Issue 1, pp 1–3

The Adjectives of Inpatient Glycemic Management

Invited Commentary

Keywords

Diabetes mellitus Inpatients Insulin Hyperglycemia Glycemic management 

References

  1. 1.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–67.PubMedCrossRefGoogle Scholar
  2. 2.
    Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34(3):612–6.PubMedGoogle Scholar
  3. 3.
    Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10 Suppl 2:21–33.PubMedGoogle Scholar
  4. 4.
    Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992–1000.PubMedCrossRefGoogle Scholar
  5. 5.
    Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449–61.PubMedCrossRefGoogle Scholar
  6. 6.
    Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125–39.PubMedCrossRefGoogle Scholar
  7. 7.
    Finfer S, Chittock DR, Su SY-S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.PubMedCrossRefGoogle Scholar
  8. 8.
    Griesdale DEG, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Can Med Assoc J. 2009;180(8):821–7.CrossRefGoogle Scholar
  9. 9.
    Qaseem A, Humphrey L, Chou R, Snow V, Shekelle P, for the Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154(4):260–7.PubMedGoogle Scholar
  10. 10.
    Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011;154(4):268–82.PubMedGoogle Scholar
  11. 11.
    Kosiborod M, Inzucchi SE, Goyal A, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301(15):1556–64.PubMedCrossRefGoogle Scholar
  12. 12.
    Van den Berghe G. First do no harm … hypoglycemia or hyperglycemia? Crit Care Med. 2006;34(11):2843–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109(12):1497–502.PubMedCrossRefGoogle Scholar
  14. 14.
    Van den Berghe G, Schetz M, Vlasselaers D, et al. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94(9):3163–70.PubMedCrossRefGoogle Scholar
  15. 15.
    Hirsch IB. Sliding scale insulin–time to stop sliding. JAMA. 2009;301(2):213–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Umpierrez G, Maynard G. Glycemic chaos (not glycemic control) still the rule for inpatient care: how do we stop the insanity? J Hosp Med. 2006;1(3):141–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157(5):545–52.PubMedCrossRefGoogle Scholar
  18. 18.
    Moghissi ES, Korytkowski MT, DiNardo MM, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.PubMedCrossRefGoogle Scholar
  19. 19.
    Mesotten D, van den Berghe G. Glycemic targets and approaches to management of the patient with critical illness. Curr Diab Rep. 2011. doi:10.1007/s11892-011-0241-8.
  20. 20.
    Pichardo-Lowden A, Gabbay RA. Management of hyperglycemia during the perioperative period. Curr Diab Rep. 2011. doi:10.1007/s11892-011-0239-2.
  21. 21.
    Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Noschese M, Donihi AC, Koerbel G, et al. Effect of a diabetes order set on glycaemic management and control in the hospital. Qual Saf Health Care. 2008;17(6):464–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Magee MF, Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract. 2004;10 Suppl 2:81–8.PubMedGoogle Scholar
  25. 25.
    Wei NJ, Wexler DJ. Basal-Bolus Insulin Protocols Enter the Computer Age. Curr Diab Rep. 2011. doi:10.1007/s11892-011-0240-9.
  26. 26.
    Wexler DJ, Shrader P, Burns SM, Cagliero E. Effectiveness of a computerized insulin order template in general medical inpatients with type 2 diabetes: a cluster randomized trial. Diabetes Care. 2010;33(10):2181–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Maynard G, Lee J, Phillips G, et al. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med (Online). 2009;4(1):3–15.CrossRefGoogle Scholar
  28. 28.
    Gosmanov AR, Umpierrez GE. Medical Nutrition Therapy in Hospitalized Patients with Diabetes. Curr Diab Rep. 2011. doi:10.1007/s11892-011-0236-5.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of Endocrinology and MetabolismUniversity of Pittsburgh School of MedicinePittsburghUSA
  2. 2.University of Pittsburgh Medical CenterPittsburghUSA

Personalised recommendations